Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update May 13, 2022 8:23am EDT
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology Apr 07, 2022 8:23am EDT
Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update Mar 31, 2022 5:24pm EDT
Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List Mar 29, 2022 8:23am EDT
Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology Mar 04, 2022 8:23am EST
